Answers are grounded in this paper and cite their sources.
Randomized trial reveals dual antiplatelet therapy beneficial for stroke associated with patent foramen ovale, indicating the importance of timely imaging.
A 46-year-old woman without traditional vascular risk factors presented with one week of persistent vertigo and a nonfocal neurologic examination. Brain MRI revealed an acute to early subacute infarct in the left paramedian pons. CT angiography of the head and neck demonstrated no large-vessel disease, and a thrombophilia panel was unremarkable. Further evaluation identified a patent foramen ovale (PFO) with an atrial septal aneurysm and septal bowing, with a large right-to-left shunt on transthoracic echocardiography and a moderate shunt on transesophageal echocardiography bubble study. She had a Risk of Paradoxical Embolism (RoPE) score of 7 and met PFO-Associated Stroke Causal Likelihood (PASCAL) "Probable" criteria. Isolated paramedian pontine infarction is classically attributed to branch atheromatous disease, but the absence of small-vessel disease markers, the posterior circulation lesion location, and high-risk PFO anatomy together favored a paradoxical embolic mechanism. She received dual antiplatelet therapy followed by aspirin monotherapy, with referral for percutaneous PFO closure. This case illustrates how RoPE and PASCAL can help estimate whether a detected PFO is likely pathogenic rather than incidental in a perforator-territory stroke, and underscores that persistent vertigo without focal deficits warrants timely stroke imaging.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: